About the course
The healthcare sector is thriving in the UK. There are numerous growth drivers attributed to this, including an ageing population and the increasing influence of technology, both of which are creating significant opportunity for the private equity and venture capital sector. This means there are many opportunities in the market but also demand for deals means high prices.
09:00 Welcome Leon de Bono, Assistant Director, BVCA
09:05 Market overview: Done deals and market trends in 2019/20
09:15 Access to Finance Report – The Findings Andrew Davies, Digital Health Lead, ABHI
09:25 Where are we in the cycle of investment, and how is consolidation affecting the healthcare industry
Moderator: Sharon Lamb, Partner, McDermott, Will & Emery Alan Mackay, Executive Partner & Founder, GHO Capital
09:50 Becoming a Unicorn: An interview with Dr Ali Parsa of Babylon Health Ali Parsa, CEO & Founder, Babylon Health
10:00 Innovation, data and digital health: how technology is developing a patient centric approach?
Moderator: Andrew Davies, Digital Health Lead, ABHI Ali Parsa, CEO & Founder, Babylon Health Anne-Laure Meynier, Investment Director, Apposite Capital Joe Stringer, Co-Founder & Managing Partner, TenX Health Tim Haines, Founding Partner, Abingworth
10:25 Accelerated Access Collaborative: The NHS' front door for Innovation Dr. Sam Roberts, Chief Executive of the Accelerated Access Collaborative and Director of Innovation, Research and Life Sciences, NHS England and NHS Improvement
11:15 Are LPs looking for sector-specific funds or simply best in class sector-focused teams to generate returns? Peter Maher, Senior Investment Director, Cambridge Associates
11:25 CEO Presentation
11:35 A growing demand for FemTech/FemCare: right time – wrong term?
Pooja Sikka, Co-Founder & General Partner, TenX Health Elena Montea, Principal, Hambro Perks
12:00 CEO Presentation – Genomes.IO Aldo de Pape, Associate Founder & CEO, Genomes.IO
12:10 Healthcare and the intersection of genetics and blockchain
Aldo de Pape, Associate Founder & CEO, Genomes.IO David Porter, Founding Partner, Apposite Capital Shane Kehoe, Co-Founding Partner, SVK Crypto
12:35 Closing remarks
Because of COVID-19, many providers are cancelling or postponing in-person programs or providing online participation options.
We are happy to help you find a suitable online alternative.